Department of Neuroscience, Psychiatry, Uppsala University, Uppsala, Sweden.
Department of Medicine Solna, Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.
J Affect Disord. 2021 Sep 1;292:276-283. doi: 10.1016/j.jad.2021.05.078. Epub 2021 Jun 5.
Response rates after and tolerability of electroconvulsive therapy (ECT) in depressive disorders with psychiatric comorbidity are uncertain.
Data on patients with a depressive episode and a first course of ECT were collected from the Swedish National Quality Register for ECT. Logistic regression analyses, adjusted for gender, age, and depressive episode severity, were used to compare patients with and without comorbidity. The clinical response assessment Clinical Global Impression - Improvement Scale was used in 4413 patients and the memory item from the Comprehensive Psychiatric Rating Scale was used for subjective memory impairment rating after ECT in 3497 patients.
In patients with depressive disorder and comorbid personality disorder or anxiety disorder, 62.7% and 73.5%, respectively, responded after ECT compared with 84.9% in patients without comorbidity [adjusted odds ratio (aOR) 0.43, 95% confidence interval (CI) 0.34-0.55, and aOR 0.61, 95% CI 0.51-0.73, respectively]. The proportion of responding patients with comorbid alcohol use disorder was 77.1%, which was not significantly different from that in patients without comorbidity (aOR 0.75, 95% CI 0.57-1.01). The impact of comorbidity decreased with higher age and depressive episode severity. Subjective ratings of memory impairment did not differ between patients with and without comorbidity.
Observational non-validated clinical data.
The response rate after ECT in depression may be lower with concurrent personality disorder and anxiety disorder; however, the majority still respond to ECT. This implies that psychiatric comorbidity should not exclude patients from ECT.
伴发精神疾病的抑郁障碍患者接受电抽搐治疗(ECT)后的反应率和耐受性尚不确定。
从瑞典国家 ECT 质量登记处收集了伴或不伴共病的抑郁发作患者的 ECT 初始疗程数据。使用逻辑回归分析,根据性别、年龄和抑郁发作严重程度进行调整,比较了伴或不伴共病的患者。4413 例患者采用临床总体印象-改善量表评估临床反应,3497 例患者采用综合精神病评定量表的记忆项目评估 ECT 后主观记忆障碍程度。
在伴发人格障碍或焦虑障碍的抑郁障碍患者中,分别有 62.7%和 73.5%在 ECT 后有反应,而无共病的患者为 84.9%[调整后比值比(aOR)分别为 0.43(95%可信区间[CI]:0.34-0.55)和 0.61(95%CI:0.51-0.73)]。伴发酒精使用障碍的有反应患者比例为 77.1%,与无共病患者相比无显著差异(aOR 0.75,95%CI:0.57-1.01)。共病对反应的影响随着年龄和抑郁发作严重程度的增加而降低。有或无共病患者的记忆障碍主观评分无差异。
观察性、非验证性临床数据。
伴发人格障碍和焦虑障碍的抑郁患者接受 ECT 后的反应率可能较低;然而,大多数患者仍对 ECT 有反应。这意味着精神共病不应将患者排除在 ECT 之外。